| Session | Time | Topic |
|---|---|---|
| Pre-Conference Workshops on 12 February 2027 (Details shall be updated soon) |
||
| 1 | Flow MRD | |
| 2 | Cytogenetics | |
| 3 | Imaging | |
| 4 | Nursing and care of central venous devices | |
| Session | Time | Topic |
|---|---|---|
| 12:00 – 1:00 PM | Quiz Prelims: All Teams | |
| 12:30 – 1:30 PM | Lunch (in NINE) | |
| Session 1 | PRECURSOR CONDITIONS & SMOLDERING MYELOMA | |
| 1:35 – 1:45 PM | Epidemiology of Plasma cell dyscrasias in India | |
| 1:45 – 2:00 PM | Evolving novel techniques for paraprotein detection | |
| 2:00 – 2:25 PM | Debate: Should We Treat High-Risk Smoldering Myeloma in India Today? For: To treat Against: Not to treat |
|
| 2:25 – 2:40 PM | Who, When, and How to Treat precursor conditions (including Smoldering Myeloma): Lessons for India from Global Trials | |
| 2:40 – 3:00 PM | RUNNING TEA BREAK & INTERACTION | |
| Session 2 | MONOCLONAL GAMMOPATHY-RELATED DISEASES | |
| 3:00 – 3:15 PM | MGRS | |
| 3:15 – 3:30 PM | MGRS Indian Data / Monoclonal gammopathy of clinical significance | |
| 3:30 – 3:45 PM | Monoclonal gammopathy of clinical significance | |
| 3:45 – 4:15 PM | Panel discussion: MGUS, SMM, MGCS | |
| 4:15 – 4:30 PM | RUNNING TEA BREAK & INTERACTION | |
| Session 3 | NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | |
| 4:30 – 4:45 PM | Risk stratification of newly diagnosed MM | |
| 4:45 – 5:00 PM | Frontline Therapy of transplant-eligible NDMM in 2027 | |
| 5:00 – 5:15 PM | Frontline Therapy of transplant-ineligible NDMM in 2027 | |
| 5:15 – 5:50 PM | Panel: Real-world practice of treatment of NDMM in India | |
| 6:00 – 7:30 PM | Conference Inauguration | |
| End of Day 1 : Dinner at PGI Community Center (Sector 24, Chandigarh) – 7:30 PM onwards | ||
| Session | Time | Topic |
|---|---|---|
| 7:45 – 8:45 AM | Mentor–Mentee Breakfast Interaction Session | |
| 9:00 – 10:00 AM | CPC | |
| Session 4 | NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | |
| 10:00 – 10:25 AM | Debate: Role of Auto HSCT in Myeloma For: Alive and kicking Against: Dead and Buried |
|
| 10:25 – 10:40 AM | Current status of Maintenance therapy in Myeloma | |
| 10:40 – 11:00 AM | Different facets of relapse and clinical implications (biochemical vs clinical, speed of relapse) | |
| 11:00 – 11:15 AM | RUNNING TEA BREAK | |
| Session 5 | RELAPSED MULTIPLE MYELOMA | |
| 11:15 – 11:30 AM | Role of ADC in Relapsed Myeloma | |
| 11:30 – 11:45 AM | Role of BiTEs in Relapsed Myeloma | |
| 11:45 AM – 12:00 Noon | Role of CAR T-cell therapy in Relapsed Myeloma | |
| 12:00 – 12:15 PM | Role of traditional agents in Relapsed Myeloma | |
| 12:15 – 1:00 PM | Panel: Balancing Efficacy, Toxicity, and Access in Relapsed Myeloma in India | |
| 1:00 – 2:00 PM | LUNCH | |
| 2:00 – 3:15 PM | Mini Oral Presentations + Company Symposium + Poster | |
| 3:15 – 3:30 PM | TEA | |
| Session 6 | POEMS | |
| 3:30 – 3:45 PM | POEMS update | |
| 3:45 – 5:00 PM | POEMS Indian Data | |
| 5:00 – 5:20 PM | RUNNING TEA BREAK | |
| Session 7 | AMYLOIDOSIS | |
| 5:20 – 5:35 PM | Clinical manifestations and challenges in diagnosis of Amyloidosis | |
| 5:35 – 5:50 PM | Management of amyloidosis | |
| 5:50 – 6:30 PM | Panel discussion on Amyloidosis | |
| 6:30 – 7:15 PM | Cultural Event | |
| End of Day 2 : Dinner Symposium + Dinner – 7:30 PM onwards | ||
| Session | Time | Topic |
|---|---|---|
| 7:45 – 8:45 AM | Interactive Quiz with Trainees | |
| 9:00 – 10:00 AM | Final Oral Paper Session | |
| 10:00 – 10:15 AM | TEA BREAK | |
| Parallel Session | 10:00 – 11:00 AM | Parallel Session – Patient Group meeting |
| Session 8 | ||
| 10:15 – 10:30 AM | Sequencing therapies in relapsed MM | |
| 10:30 – 10:45 AM | How to overcome T cell exhaustion in Multiple Myeloma | |
| 10:45 – 11:00 AM | Prevention and management of infections in Myeloma | |
| 11:00 – 11:45 AM | Challenges, treatment access and opportunities in Myeloma care in South Asia | |
| 11:45 AM – 12:00 Noon | Myeloma Cure: Light at the end of the tunnel | |
| 12:00 Noon : Prize Distribution and Closing Ceremony | ||